Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,8799 USD | +1,49 % | +1,25 % | -24,15 % |
Resumen de negocios
Número de empleados: 68
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Genetic Diagnostic Testing
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +69,00 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Germany
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +69,00 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Guido Baechler
CEO | Chief Executive Officer | 59 | 01/07/21 |
William Caragol
DFI | Director of Finance/CFO | 58 | 01/07/21 |
Corinna Gorges
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/21 |
Chief Tech/Sci/R&D Officer | - | 03/08/22 | |
Moritz Eidens
CTO | Chief Tech/Sci/R&D Officer | 41 | - |
Stefan Erlach
HRO | Human Resources Officer | - | - |
Amy Levin
LAW | General Counsel | - | 29/11/22 |
Jane Edwards
PRN | Corporate Officer/Principal | - | 14/06/22 |
Steve Quinn
PRN | Corporate Officer/Principal | - | 27/01/22 |
Philipp Freese
PRN | Corporate Officer/Principal | 42 | 01/02/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gregory Tibbitts
BRD | Director/Board Member | 57 | 14/12/22 |
Heiner Dreismann
CHM | Chairman | 69 | 14/12/22 |
Director/Board Member | 66 | 01/11/21 | |
Guido Baechler
CEO | Chief Executive Officer | 59 | 01/07/21 |
Moritz Eidens
CTO | Chief Tech/Sci/R&D Officer | 41 | - |
Nicole Holden
BRD | Director/Board Member | 51 | 01/11/21 |
Alberto Libanori
BRD | Director/Board Member | 35 | 01/11/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 21 886 575 | 17 151 888 ( 78,37 %) | 0 | 78,37 % |
Información de la empresa
Mainz Biomed NV
Sirius Gutenberg Park Robert Koch Strasse 50
55129, Mainz
+49 6131 554 2860
http://mainzbiomed.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-24,15 % | 19,26 M | |
-17,39 % | 8351,46 M | |
+39,49 % | 3583,94 M | |
-38,71 % | 2462,56 M | |
-8,06 % | 2467,54 M | |
-7,96 % | 2360,56 M | |
-13,97 % | 1777,11 M | |
-19,73 % | 1525,12 M | |
-40,78 % | 1206,67 M | |
+8,32 % | 1115,64 M |
- Bolsa de valores
- Acciones
- Acción MYNZ
- Empresa Mainz Biomed N.V.